Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Clinical management of gastrointestinal stromal tumors: before and after STI-571.

Dematteo RP, Heinrich MC, El-Rifai WM, Demetri G.

Hum Pathol. 2002 May;33(5):466-77.

PMID:
12094371
2.

Targeting c-kit mutations in solid tumors: scientific rationale and novel therapeutic options.

Demetri GD.

Semin Oncol. 2001 Oct;28(5 Suppl 17):19-26. Review.

PMID:
11740803
4.

Current clinical management of gastrointestinal stromal tumors.

Tosoni A, Nicolardi L, Brandes AA.

Expert Rev Anticancer Ther. 2004 Aug;4(4):595-605. Review.

PMID:
15270663
5.

Diagnosis of gastrointestinal stromal tumors: A consensus approach.

Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, Miettinen M, O'Leary TJ, Remotti H, Rubin BP, Shmookler B, Sobin LH, Weiss SW.

Hum Pathol. 2002 May;33(5):459-65. Review.

PMID:
12094370
6.

Gastrointestinal stromal tumours.

Connolly EM, Gaffney E, Reynolds JV.

Br J Surg. 2003 Oct;90(10):1178-86. Review.

PMID:
14515284
7.

[Gastrointestinal stromal tumors (GIST)].

Reichardt P, Pink D, Mrozek A, Lindner T, Hohenberger P.

Z Gastroenterol. 2004 Apr;42(4):327-31. Review. German.

PMID:
15095124
8.

Gastrointestinal stromal tumors (GIST): a model for molecule-based diagnosis and treatment of solid tumors.

Kitamura Y, Hirota S, Nishida T.

Cancer Sci. 2003 Apr;94(4):315-20. Review. Erratum in: Cancer Sci. 2003 Oct;94(10):930.

9.

Gastrointestinal stromal tumors and the evolution of targeted therapy.

Sanborn RE, Blanke CD.

Clin Adv Hematol Oncol. 2005 Aug;3(8):647-57. Review.

PMID:
16167051
10.

Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review.

Miettinen M, El-Rifai W, H L Sobin L, Lasota J.

Hum Pathol. 2002 May;33(5):478-83. Review.

PMID:
12094372
11.

Gastrointestinal stromal tumors--a review.

Joensuu H, Kindblom LG.

Acta Orthop Scand Suppl. 2004 Apr;75(311):62-71. Review.

PMID:
15188667
12.

[Small-molecule inhibitors against KIT and PDGFRs especially in GISTs].

Shiba K, Matsumoto T, Hirota S.

Gan To Kagaku Ryoho. 2009 Jul;36(7):1080-5. Review. Japanese.

PMID:
19620796
13.

Pathology of gastrointestinal stromal tumors.

Hirota S, Isozaki K.

Pathol Int. 2006 Jan;56(1):1-9. Review.

PMID:
16398673
14.

Surgery and imatinib in the management of GIST: emerging approaches to adjuvant and neoadjuvant therapy.

Eisenberg BL, Judson I.

Ann Surg Oncol. 2004 May;11(5):465-75. Review.

PMID:
15123459
15.

Imatinib mesylate acts in metastatic or unresectable gastrointestinal stromal tumor by targeting KIT receptors--a review.

Sawaki A, Yamao K.

Cancer Chemother Pharmacol. 2004 Sep;54 Suppl 1:S44-9. Review.

PMID:
15309514
16.

Management of gastrointestinal stromal tumors: from diagnosis to treatment.

Bucher P, Villiger P, Egger JF, Buhler LH, Morel P.

Swiss Med Wkly. 2004 Mar 20;134(11-12):145-53. Review.

PMID:
15106018
17.

Gastrointestinal stromal tumour--a paradigm shift in management of solid tumours.

Bapsy PP, Prabhash K, Babu KG, Girish MH.

J Assoc Physicians India. 2003 Aug;51:801-4. Review.

PMID:
14651144
18.

Role of imatinib mesylate (Gleevec/Glivec) in gastrointestinal stromal tumors.

de Jong FA, Verweij J.

Expert Rev Anticancer Ther. 2003 Dec;3(6):757-66. Review.

PMID:
14686698
19.

[At last, an effective therapy for non-differentiated GI sarcomas (gastro intestinal stromal tumor)].

Des Guetz G, De Mestier P, Pierga JY.

J Chir (Paris). 2002 Oct;139(5):268-73. Review. French. Erratum in: J Chir (Paris). 2002 Dec;139(6):368..

PMID:
12410126
20.

Role of c-kit/SCF in cause and treatment of gastrointestinal stromal tumors (GIST).

Ali S, Ali S.

Gene. 2007 Oct 15;401(1-2):38-45. Epub 2007 Jul 3. Review.

PMID:
17659849

Supplemental Content

Support Center